# Dose Defining Study for the Administration of Vitamin K2 Supplements in Hemodialysis Patients

> **NCT01675206** · PHASE3 · COMPLETED · sponsor: **Rogier Caluwe** · enrollment: 165 (actual)

## Conditions studied

- Vascular Calcification

## Interventions

- **DIETARY_SUPPLEMENT:** Vitamin K2 supplementation

## Key facts

- **NCT ID:** NCT01675206
- **Lead sponsor:** Rogier Caluwe
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-09
- **Final completion:** 2012-04
- **Target enrollment:** 165 (ACTUAL)
- **Last updated:** 2012-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01675206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01675206, "Dose Defining Study for the Administration of Vitamin K2 Supplements in Hemodialysis Patients". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01675206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*